Camp4 Therapeutics (CAMP) Accumulated Expenses (2023 - 2026)

Camp4 Therapeutics has reported Accumulated Expenses for 4 years, with the latest figure at $4.3 million in Q1 2026.

• Quarterly Accumulated Expenses rose 134.06% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (up 134.06% YoY) and the FY2025 annual result came in at $5.7 million, up 17.09% from the prior year.
• Accumulated Expenses eased to $4.3 million in Q1 2026 per CAMP's latest filing, from $5.7 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $5.7 million in Q4 2025 and troughed at $1.8 million in Q1 2025.
• A 4-year average of $3.8 million and a median of $3.9 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2025 and 2026: Accumulated Expenses rose 10.55% in 2025, then jumped 134.06% in 2026.
• Over 4 years, Accumulated Expenses stood at $3.3 million in 2023, then jumped by 46.37% to $4.8 million in 2024, then rose by 17.09% to $5.7 million in 2025, then slipped by 23.98% to $4.3 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $4.3 million, $5.7 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.